Impact of HIF-PH inhibitors on diabetic macular edema and diabetic retinopathy, multicenter study

Impact of Hypoxia Inducible Factor Prolyl Hydoxylase inhibitors on diabetic macular edema and diabetic retinopathy, multicenter study - Impact of HIF-PH inhibitors on DME

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051104

Enrollment

200

Registered

2023-05-19

Start date

2023-04-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal anemia, diabetic retinopathy, diabetic macular edema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with diabetes mellitus who visited the ophthalmologist from the date of approval by the head of the research institution to March 31, 2028 2. Patients with visual acuity and OCT imaging data before and after the start of HIF-PH administration

Exclusion criteria

Exclusion criteria: 1.Blind in both eyes 2. Inability to perform OCT examination 3. Other patients who are judged as unfit by the ophthalmologist

Design outcomes

Primary

Measure	Time frame
OCT findings including retinal thickness. visual acuity. Hemoglobin and other blood tests to assess the degree of anemai.	—

Secondary

Measure	Time frame
The progression of diabetic malular edema and retinopathy (Fundus photography or observation)	—

Countries

Japan

Contacts

Public ContactHideyuki Oshima

university of Fukui Hospital Ophthalmology

osm@g.u-fukui.ac.jp776618403

Outcome results